Article

Expression characteristics of activated T lymphocytes in patients with multiple myeloma

2024-01-30

Abstract excerpt

<h4>Objective: </h4> An active role for the immune system in controlling the progress of multiple myeloma (MM) has been postulated for many years. However, the T-cells and their phenotype in MM remain to be elucidated. In this study, we compared the phenotype of T-cells in MM patients and healthy donors. The expression of chemokine recepptor marker (CCR7), senescent marker (CD57) , co-stimulator marker(CD28), acti...

Identifiers and source

Literature Corpus work: ec38172e-a2b3-5e08-a67d-58deaa3b1f6b
DOI: 10.22541/au.170663632.22698938/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Expression characteristics of activated T lymphocytes in patients with multiple myelomaDOI 10.22541/au.170663632.22698938/v1Read

Profound CD4+ T-Cell Reprogramming by Melphalan-Driven Oxidative Stress in High-Risk Multiple MyelomaSemantic proximity Read

Proliferative CD8 T-cells : A Novel Immune Microenvironmental Determinant of Outcomes in Multiple MyelomaSemantic proximity Read

A single-cell atlas characterizes dysregulation of the bone marrow immune microenvironment associated with outcomes in multiple myelomaSemantic proximity Read

Mechanisms of resistance to CAR-T cell therapy in multiple myeloma: latest updates from the 2024 ASH annual meetingSemantic proximity Read

Genotype-immunophenotype analysis reveals the immunogenomic subtype and prognosis of multiple myeloma.Semantic proximity Read

Identification of Immune-Related Hub Genes in Multiple MyelomaSemantic proximity Read

CARving a Path Forward: Unveiling T Cell Phenotypes Across the Spectrum of Multiple Myeloma Disease Progression to Inform Future Strategies for Overcoming Resistance to CAR T Therapy.Semantic proximity Read

Identification of Pathogenesis and Prognoses of Relapse in Myeloma by Bioinformatic MethodSemantic proximity Read

Deep Phenotyping Reveals Distinct Immune Signatures Correlating with Prognostication, Treatment Responses, and MRD Status in Multiple MyelomaSemantic proximity Read

Comprehensive Characterization of the Multiple Myeloma Immune Microenvironment Using Integrated scRNA-seq, CyTOF, and CITE-seq AnalysisSemantic proximity Read

Functional Role of Granulocytic Myeloid-Derived Suppressor Cells in CAR-T Therapy: Insights from Single- Cell RNA Sequencing in Multiple MyelomaSemantic proximity Read

Favorable response to daratumumab combination therapy in patients with multiple myeloma with an immature phenotype: a report from the J-CHARGE study group.Semantic proximity Read